{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-065563","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.437695+00:00","generated_at":"2026-06-14T13:11:55.291165+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bicycle Therapeutics registers up to $150M additional ADS sale under ATM facility","bullets":["Filed prospectus supplement on May 26, 2023, to sell up to $150M in ADSs via existing Sales Agreement with Cantor Fitzgerald and Oppenheimer.","Sales agents will receive 3% commission on gross proceeds; offering is an 'at the market' program under Rule 415.","Company is not obligated to sell any shares; sales at its discretion subject to market conditions.","The original Controlled Equity Offering agreement was dated June 5, 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-065563","json":"https://secwatch.observer/filing/0001104659-23-065563.json","markdown":"https://secwatch.observer/filing/0001104659-23-065563.md","text":"https://secwatch.observer/filing/0001104659-23-065563.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/0001104659-23-065563-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/tm2317110d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T13:11:55.291165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}